Evidence map›Paper›PMID 40126731›Full record

ReviewHuman cell2025

Advances in the study of single-walled carbon nanotubes in ophthalmology.

Junyu Wang, Ying Su, Feng Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Human cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junyu WangDepartment of Ophthalmology, the Fourth Affiliated Hospital, Harbin Medical University, Harbin, China.
Ying SuEye Hospital, the First Affiliated Hospital, Harbin Medical University, Harbin, China. suying0511@126.com.
Feng WangDepartment of Ophthalmology, the Fourth Affiliated Hospital, Harbin Medical University, Harbin, China. wangfd@126.com.ORCID http://orcid.org/0009-0007-0526-4717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of nanotechnology, the application of nanomaterials in the medical field shows unprecedented potential and innovative prospects. In particular, single-walled carbon nanotubes (SWCNTs), due to their unique physicochemical properties such as high surface area, excellent thermal and electrical properties, high surface/volume aspect ratio, and high tensile strength, show great potential for application in biomedical and biotechnological fields. Ophthalmology, as a branch of medicine that requires great precision and innovation, is gradually becoming one of the hotspots for nanotechnology applications. Although the research and application of nanomaterials in ophthalmology have made some progress, the potential of SWCNTs in ophthalmology has not yet been explored. This paper is a comprehensive review of the applications of nanomaterials in ophthalmology, including their use in drug delivery, antimicrobials, imaging, tissue repair, and photodynamic therapy, and further explores the similar roles of SWCNTs in other medical fields, thus speculating on their potentially important value in ophthalmic research.

Indexed as

NanotechnologyNanotubes, CarbonOphthalmologyAnti-Infective AgentsDrug Delivery SystemsHumansPhotochemotherapyAnti-Infective AgentsNanotubes, CarbonNanomaterialsNanomedicineOphthalmologySingle-walled carbon nanotubes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.